92 related articles for article (PubMed ID: 28668897)
1. Hepatectomy for Liver Metastases of Colorectal Cancer After Adoptive Chemoimmunotherapy Using Activated αβ T-cells.
Ishii F; Yoshida Y; Yamauchi Y; Aisu N; Kojima D; Mera T; Kato D; Tanaka T; Naito K; Yasumoto K; Kamigaki T; Goto S; Hamada Y; Nimura S; Kodama S; Hasegawa S
Anticancer Res; 2017 Jul; 37(7):3933-3939. PubMed ID: 28668897
[TBL] [Abstract][Full Text] [Related]
2. Clinical Study on the Medical Value of Combination Therapy Involving Adoptive Immunotherapy and Chemotherapy for Stage IV Colorectal Cancer (COMVI Study).
Yoshida Y; Naito M; Yamada T; Aisu N; Kojima D; Mera T; Tanaka T; Naito K; Yasumoto K; Kamigaki T; Gotoh S; Kodama S; Yamashita Y; Hasegawa S
Anticancer Res; 2017 Jul; 37(7):3941-3946. PubMed ID: 28668898
[TBL] [Abstract][Full Text] [Related]
3. Adoptive Chemoimmunotherapy Using Activated αβ T Cells for Stage IV Colorectal Cancer.
Yoshida Y; Naito M; Yamada T; Aisu N; Daibo K; Mera T; Tanaka T; Naito K; Yasumoto K; Kamigaki T; Goto S; Yamashita Y; Hasegawa S
Anticancer Res; 2016 Jul; 36(7):3741-6. PubMed ID: 27354648
[TBL] [Abstract][Full Text] [Related]
4. [Pathological Complete Response in a Case of Multiple Liver Metastases from Rectal Cancer Treated with XELOX plus Bevacizumab(Bev)Therapy].
Noura S; Shuto T; Muratsu A; Yoshida Y; Yasuyama A; Matsumura T; Koga C; Kameda C; Murakami M; Kawabata R; Hirota M; Yoshikawa M; Shimizu J; Hasegawa J; Miwa H
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1742-1744. PubMed ID: 28133117
[TBL] [Abstract][Full Text] [Related]
5. [XELOX plus Bevacizumab Chemotherapy for a Patient with Postoperative Recurrence of Colorectal Cancer Under Hemodialysis for Chronic Renal Failure].
Takeda T; Miyake M; Tanaka K; Uemura M; Ikeda M; Maeda S; Yamamoto K; Hama N; Nishikawa K; Miyamoto A; Miyazaki M; Hirao M; Nakamori S; Sekimoto M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1594-6. PubMed ID: 26805107
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
[TBL] [Abstract][Full Text] [Related]
7. Changes in Immunological Status in Patients With Metastatic Colorectal Cancer Treated With First-line Chemoimmunotherapy.
Yamada T; Yoshida Y; Maeda T; Yoshimatsu G; Aisu N; Yamashita K; Komono A; Kajitani R; Matsumoto Y; Nagano H; Naito K; Yasumoto K; Takimoto R; Kamigaki T; Goto S; Yoshimura F; Sakata N; Kodama S; Hasegawa S
Anticancer Res; 2020 Aug; 40(8):4763-4771. PubMed ID: 32727803
[TBL] [Abstract][Full Text] [Related]
8. Feasibility study of oxaliplatin with oral S-1 or capecitabine as first-line therapy for patients with metastases from colorectal cancer.
Watanabe K; Kawahara H; Enomoto H; Toyama Y; Akiba T; Yanaga K
Anticancer Res; 2013 Sep; 33(9):4029-32. PubMed ID: 24023346
[TBL] [Abstract][Full Text] [Related]
9. [Systemic chemotherapy and surgery for recurrent metachronous liver metastases with peritoneal dissemination from triple colon cancers-a case report].
Kato T; Noda H; Watanabe F; Kakizawa N; Toyama N; Rikiyama T
Gan To Kagaku Ryoho; 2014 Dec; 41(13):2615-7. PubMed ID: 25596059
[TBL] [Abstract][Full Text] [Related]
10. Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen study.
Pilancı KN; Saglam S; Okyar A; Yucel S; Pala-Kara Z; Ordu C; Namal E; Ciftci R; Iner-Koksal U; Kaytan-Saglam E
Cancer Chemother Pharmacol; 2016 Jul; 78(1):143-50. PubMed ID: 27270460
[TBL] [Abstract][Full Text] [Related]
11. [Preoperative chemotherapy enabled radical resection of tumors in a patient with multiple liver metastases].
Shimizu K; Doi K; Ogawa K; Iwatsuki M; Tanaka H; Sugiyama S; Ogata K; Takamori H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1743-5. PubMed ID: 25731315
[TBL] [Abstract][Full Text] [Related]
12. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients.
Coskun U; Buyukberber S; Yaman E; Uner A; Er O; Ozkan M; Dikilitas M; Oguz M; Yildiz R; B DY; Kaya AO; Benekli M
Neoplasma; 2008; 55(1):65-70. PubMed ID: 18190244
[TBL] [Abstract][Full Text] [Related]
13. Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study.
Santini D; Vincenzi B; Schiavon G; Di Seri M; Virzí V; Spalletta B; Caricato M; Coppola R; Tonini G
Cancer Chemother Pharmacol; 2007 Apr; 59(5):613-20. PubMed ID: 16944151
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR study.
Bennouna J; Borg C; Delord JP; Husseini F; Trillet-Lenoir V; Faroux R; François E; Ychou M; Goldwasser F; Bouché O; Senellart H; Kraemer S; Douillard JY
Clin Colorectal Cancer; 2012 Mar; 11(1):38-44. PubMed ID: 21803002
[TBL] [Abstract][Full Text] [Related]
15. Preoperative Chemotherapy with Bevacizumab Extends Disease-free Survival After Resection of Liver Metastases from Colorectal Cancer.
Umehara M; Umehara Y; Takahashi K; Murata A; Nishikawa S; Tokura T; Matsuzaka M; Tanaka R; Morita T
Anticancer Res; 2016 Apr; 36(4):1949-54. PubMed ID: 27069185
[TBL] [Abstract][Full Text] [Related]
16. [Recurrent liver sigmoid cancer responding remarkably to neoadjuvant chemotherapy using bevacizumab/XELOX: report of a case].
Uehara M; Sakamoto K; Konishi S; Hamasu S; Nishitai R; Manaka D
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1541-3. PubMed ID: 21918359
[TBL] [Abstract][Full Text] [Related]
17. Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.
Tamandl D; Klinger M; Eipeldauer S; Herberger B; Kaczirek K; Gruenberger B; Gruenberger T
Ann Surg Oncol; 2011 Feb; 18(2):421-30. PubMed ID: 20844968
[TBL] [Abstract][Full Text] [Related]
18. Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.
Kandutsch S; Klinger M; Hacker S; Wrba F; Gruenberger B; Gruenberger T
Eur J Surg Oncol; 2008 Nov; 34(11):1231-6. PubMed ID: 18272318
[TBL] [Abstract][Full Text] [Related]
19. [Neoadjuvant chemotherapy with capecitabine plus oxaliplatin and bevacizumab for the treatment of patients with resectable metastatic colorectal cancer].
Kemmochi T; Egawa T; Mihara K; Ito Y; Ohkubo Y; Mori T; Nagashima A; Makino H; Yamamuro W
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1629-31. PubMed ID: 24393871
[TBL] [Abstract][Full Text] [Related]
20. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study.
Leone F; Artale S; Marino D; Cagnazzo C; Cascinu S; Pinto C; Fornarini G; Tampellini M; Di Fabio F; Sartore-Bianchi A; De Carlis L; Pugliese R; Capussotti L; Gioeni L; Siena S; Aglietta M
Cancer; 2013 Oct; 119(19):3429-35. PubMed ID: 23868516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
